New model may help breast cancer patients know their menopause risk
NCT ID NCT07497191
First seen Apr 05, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study looks at 300 women aged 45-55 with hormone-positive breast cancer who are near menopause. Researchers will track a hormone called AMH over time to see if it can predict when menopause starts. The goal is to create a tool that helps doctors choose the best hormone therapy and gives patients personalized advice about fertility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.